DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Drug development and manufacturing

Abstract

X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical, for estimating the binding selectivity of a chemical versus chemical analogs, for measuring post-translational modifications of proteins, and for drug manufacturing.

Inventors:
; ;
Issue Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1223103
Patent Number(s):
9157875
Application Number:
10/880,388
Assignee:
Warner; Benjamin P.
Patent Classifications (CPCs):
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
Y - NEW / CROSS SECTIONAL TECHNOLOGIES Y10 - TECHNICAL SUBJECTS COVERED BY FORMER USPC Y10S - TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
DOE Contract Number:  
W-7405-ENG-36
Resource Type:
Patent
Resource Relation:
Patent File Date: 2004 Jun 29
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE

Citation Formats

Warner, Benjamin P., McCleskey, T. Mark, and Burrell, Anthony K. Drug development and manufacturing. United States: N. p., 2015. Web.
Warner, Benjamin P., McCleskey, T. Mark, & Burrell, Anthony K. Drug development and manufacturing. United States.
Warner, Benjamin P., McCleskey, T. Mark, and Burrell, Anthony K. Tue . "Drug development and manufacturing". United States. https://www.osti.gov/servlets/purl/1223103.
@article{osti_1223103,
title = {Drug development and manufacturing},
author = {Warner, Benjamin P. and McCleskey, T. Mark and Burrell, Anthony K.},
abstractNote = {X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical, for estimating the binding selectivity of a chemical versus chemical analogs, for measuring post-translational modifications of proteins, and for drug manufacturing.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2015},
month = {10}
}

Works referenced in this record:

Tagged immunoassay
patent, March 1984


Fluorometirc enzyme inhibition immunoassay for measuring potency of allergen extracts
patent, July 1985


Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
patent, September 1992


Receptor polypeptides and their production and uses
patent, June 1993


Method for identifying compounds in a chemical mixture
patent, November 2000


Arrays of protein-capture agents and methods of use thereof
patent, December 2001


Apparatus for screening compound libraries
patent, May 2002


Thermal and fluidic cycling device for nucleic acid hybridization
patent, August 2002


Supported mesoporous carbon ultrafiltration membrane and process for making the same
patent, April 2004


Receptor assay
patent, September 2006


Method for detecting binding events using micro-X-ray fluorescence spectrometry
patent, December 2010


Secure records storage and retrieval system and method
patent-application, January 2003


Method for detecting binding events using micro-X-ray fluorescence spectrometry
patent-application, February 2003


Flow method and apparatus for screening chemicals using micro x-ray fluorescence
patent-application, January 2004


Instrument access control system
patent-application, May 2004


Information access system, device and method
patent-application, July 2004


Drug development and manufacturing
patent-application, November 2004


Method and Apparatus for Detecting Chemical Binding
patent-application, January 2005


Method and apparatus for managing confidential information
patent-application, January 2005


Flow method and apparatus for screening chemicals using micro x-ray fluorescence
patent-application, September 2005


Quantitation of antibody binding to cell surface antigens by X-ray fluorescence spectrometry
journal, March 1979


Micro-X-ray Fluorescence as a General High-Throughput Screening Method for Catalyst Discovery and Small Molecule Recognition
journal, May 2003


Quantification of Pt bound to DNA using total-reflection X-ray fluorescence (TXRF)
journal, January 1999


Protein Microarrays to Detect Protein–Protein Interactions Using Red and Green Fluorescent Proteins
journal, July 2002


Developing a Strategy for Activity-Based Detection of Enzymes in a Protein Microarray
journal, March 2003


Proteomics in drug discovery
journal, August 2002


Novel detection strategies for drug discovery
journal, September 2002


Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
journal, January 2002


The theoretical derivation of fluorescent X-ray intensities from mixtures
journal, January 1955


Quantitative Structure–Activity Relationship Methods: Perspectives on drug Discovery and Toxicology
journal, January 2003


Quantitative structure–activity relationships (QSARs) in toxicology: a historical perspective
journal, March 2003


The Use of a Scanning X-ray Microprobe for Simultaneous XRF/XRD Studies of Fly-Ash Particles
journal, July 1997


Micro-X-ray Fluorescence as a General High-Throughput Screening Method for Catalyst Discovery and Small Molecule Recognition
journal, May 2003


Protein chip technology
journal, February 2003


Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
journal, January 2002


Evaluation of the protein concentration in enzymes via determination of sulfur by total reflection X-ray fluorescence spectrometry — limitations of the method
journal, November 2001